Delivery Order SPE2DB22D2009-SPE2DB23FM2BZ
Award Date 6/30/23
Potential Completion Date 7/3/23
Potential Value $713
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency awarded a $10,853.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561708796 Zortress 0.75 MG tablets to be delivered to its Conshohocken, Pennsylvania facility by August 7, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will provide 0.75 MG tablets of the drug Zortress under this order to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified.</p>
- The Defense Logistics Agency awarded a $2,234.77 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4561450024 Zortress 0.75 MG tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver 60 tablets of the specified medication to its Conshohocken, Pennsylvania facility by July 11, 2023 to fulfill requirements under the contract. The prime is a division of Amerisourcebergen Corporation. No subcontractors or set aside designations were identified. The Defense...
- The Defense Logistics Agency Troop Support Medical awarded a $3,755.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562180618 Zortress 0.75 mg tablets in unit dose packaging of 60 tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order is for the purchase of the specified pharmaceutical product and has a period of performance from September 14, 2023 through September 15, 2023. No major...
- The Defense Logistics Agency awarded a delivery order valued at $356.65 to Amerisourcebergen Drug Corporation for the supply of 4562259712 Zortress 0.25 MG tablets in unit dose packaging of 60 tablets. The firm fixed price order calls for delivery to a facility in Conshohocken, Pennsylvania by September 8, 2023 to support DLA programs. Amerisourcebergen will perform as the prime contractor, drawing upon its expertise in pharmaceutical distribution for the U.S. Department of Defense. No...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $356.65 delivery order against the Defense Logistics Agency's prime vendor contract to supply 4562079152 Zortress 0.25 MG tablets. The firm fixed price order is for 60 tablets to be delivered to a facility in Conshohocken, Pennsylvania by September 8, 2023. Funding is provided by the Defense Logistics Agency to support the Department of Defense's medical supply needs. No set aside provisions or...
- The Defense Logistics Agency awarded a delivery order valued at $3,190.66 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Zortress 1 mg tablets in unit dose packaging (60 count). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $1,758.60 to AmerisourceBergen Drug Corp for Zortress 0.5 mg tablets (60 unit dose tablets) on January 2, 2026, with an ultimate completion date of January 5, 2026. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $12,930.87 delivery order to AmerisourceBergen Drug Corp for Zortress 1 mg tablets (60 unit dose packages) on December 2, 2025, with completion scheduled for December 3, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order as a child...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $3,669.85 by the Defense Logistics Agency Troop Support Medical to supply 4561568927 Zortress 0.75 MG tablets. Performance will take place in Conshohocken, Pennsylvania over a period of four days from July 21 through July 24, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the United States armed forces...
- The Defense Logistics Agency awarded a $12,994.75 delivery order to AmerisourceBergen Drug Corp for Zortress 1 mg tablets (60-unit dose packages) on September 29, 2025, with completion scheduled for September 30, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical supply to support federal medical procurement needs, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB23FM2BZDelivery Order
The Defense Logistics Agency awarded a $713 delivery order to Amerisourcebergen Drug Corporation for 4561391855 Zortress 0.25 MG tablets to be delivered within a three-day period ending July 3, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency procures pharmaceuticals and other medical commodities in support of the U.S. Department of Defense healthcare system and readiness needs. No subcontractors or set aside designations were indicated. The firm fixed price contract reflects the agency's requirement for a specified quantity of the pharmaceutical product to support its mission within a short timeframe.
Generated 12/18/23, 5:41 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $713 | 6/30/23 |